The analysis confirms that gp78 is expressed at a higher level in the breast cancers of women of African descent, is associated with gene expression patterns that are predictive of tumor recurrence and response to therapy, and demonstrates that gp78 independently predicts poor breast cancer survival in women of African ancestry even after adjusting for age, stage, grade, and subtype. Here, AMFR is linked to breast cancer.